Beryl Drugs Limited (BOM:524606)
India · Delayed Price · Currency is INR 21.72
-0.28 (-1.27%)
At close: Jul 28, 2026
Beryl Drugs Market Cap
Beryl Drugs has a market cap or net worth of 110.16 million as of July 28, 2026. Its market cap has increased by 4.42% in one year.
Market Cap
110.16M
Enterprise Value
131.83M
Revenue
188.20M
Ranking
n/a
PE Ratio
25.86
Stock Price
21.72
ChartMarket Cap Chart
Since June 14, 2005, Beryl Drugs's market cap has increased from 3.69M to 110.16M, an increase of 2,881.80%. That is a compound annual growth rate of 17.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 110.16M | -7.18% |
| Dec 31, 2025 | 118.68M | -35.27% |
| Dec 31, 2024 | 183.34M | 63.50% |
| Dec 29, 2023 | 112.14M | 70.08% |
| Dec 30, 2022 | 65.93M | 7.26% |
| Dec 31, 2021 | 61.47M | 54.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Desh Rakshak Aushdhalaya | 176.65M |
| Zenith Healthcare | 174.11M |
| Norris Medicines | 160.01M |
| Rekvina Laboratories | 152.51M |
| Shamrock Industrial Company | 134.17M |
| Emmessar Biotech & Nutrition | 122.15M |
| Ortin Global | 116.77M |
| Unjha Formulations | 106.68M |